| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3662ce5995dada5ea3d9873552592af0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 |
| filingDate |
2009-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f76abf1ebb52de5a3d0c666d60b4f54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d79733a419c6af601fe013871d31066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a76a0add6c94805922b7c8da36cc342b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04cbf65a01e4a9b0d9e519d63b4842a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fcf35c6c1d1531e2baccc4701336eec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d08473a5fa9bc66be2b5a9aa85358cdc |
| publicationDate |
2010-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7847082-B2 |
| titleOfInvention |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| abstract |
The present invention encompasses novel antibodies and fragments thereof which immunospecifically bind to one or more RSV antigens and compositions comprising said antibodies and antibody fragments. The present invention encompasses methods preventing respiratory syncytial virus (RSV) infection in a human, comprising administering to said human a prophylactically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention also encompasses methods for treating or ameliorating symptoms associated with a RSV infection in a human, comprising administering to said human a therapeutically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention further encompasses compositions comprising antibodies or fragments thereof that immunospecifically bind to a RSV antigen, and methods using said compositions for detection or diagnosis a RSV infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8007793-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011027272-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10059757-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8795661-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9283274-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8475792-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10723786-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8153133-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8323962-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9321831-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8460663-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10035843-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010189718-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11180542-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8562996-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8775090-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009175883-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8986686-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10730931-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8568726-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9272032-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8206951-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9879067-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10604560-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8012476-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9562100-B2 |
| priorityDate |
2000-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |